MedTrace Logo

Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway

NCT06387017 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2024-04-26

No results posted yet for this study

Summary

Interventional study with minimal risks and constraints, with evaluation of the incidence of lung cancers by low-dose thoracic CT scan without injection of contrast medium, of the immunological, inflammatory and metabolic blood profile and of the microbiota; systematic proposal of smoking cessation for active smokers or assistance in maintaining cessation.

Conditions

  • Smoking-related Pathology
  • Atheroma
  • Non-progressive Cancer > 5 Years
  • Lung Cancer

Interventions

DIAGNOSTIC_TEST

blood sampling

blood collection

DIAGNOSTIC_TEST

stool collection

stool collection

RADIATION

low dose CT scan

low dose CT scan evaluation

Sponsors & Collaborators

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Principal Investigators

  • Mathilde LEFEVRE · ASSISTANCEPUBLIQUE HOPTAUX DE MARSEILLE

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-02
Primary Completion
2028-07-31
Completion
2029-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06387017 on ClinicalTrials.gov